Aphria Inc reported CAD-7278000 in Gross Profit on Sales for its fourth fiscal quarter of 2020.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Ani Pharmaceuticals ANIP:US $ 27.65M 1.34M
Aurora Cannabis Inc ACB:CN 14.1M 75.17M
Canopy Growth Corp WEED:CN C$ -71140000 98.38M
Corcept Therapeutics CORT:US $ 94.86M 4.65M
Cronos Group Inc CRON:CN -15784000 12.82M
Gw Pharmaceuticals GWPH:US $ 140.66M 2.86M
Lannett LCI:US $ 16.52M 6.14M
Nektar Therapeutics NKTR:US $ 19.61M 1.05M
Pacira Pharmaceuticals PCRX:US $ 93.07M 7.27M
Supernus Pharmaceuticals SUPN:US $ 130.38M 14.08M